CNE1000011G4
CNE1000011G4
FUAN PHARM
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.738.291.062 | 2.391.468.105 | 27.3% |
| Cost of Revenue | 1.095.715.331 | 1.124.997.486 | 2.6% |
| Gross Profit | 642.575.732 | 1.266.470.619 | 49.3% |
| 546.200.361 | 958.291.146 | 43.0% | |
| Operating Income | 96.375.370 | 308.179.473 | 68.7% |
| Pretax Income | 83.243.576 | 312.196.554 | 73.3% |
| Net Income Common Stockholders | 76.997.130 | 279.837.281 | 72.5% |
| -- | -- | -- | |
| -- | -- | -- |